Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
APL-MTNSE
Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 38% | 61% |
| - | - | 239% | 218% |
| - | - | - | 72% |
| 42% | 42% | 52% | 51% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
APL-MT
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,780.4 | ₹425150 Cr | 38.77 | 8.29 | 58.23 | ₹11479 Cr |
| 10,003.3 | ₹266265 Cr | 91.03 | 34.04 | 128.41 | ₹2568 Cr |
| 4,689 | ₹176301 Cr | 83 | 14.04 | 106.21 | ₹2163 Cr |
| 2,318.1 | ₹125352 Cr | 93.56 | 8.17 | 33.94 | ₹889 Cr |
| 1,200.05 | ₹123591 Cr | 27.39 | 9.42 | 62.53 | ₹5040 Cr |
| 1,367.7 | ₹114351 Cr | 40.84 | 11.08 | 59.2 | ₹4196 Cr |
| 1,395.8 | ₹112474 Cr | 38.82 | 10.86 | 52.6 | ₹3879 Cr |
| 2,502.55 | ₹102315 Cr | 45.62 | 17.23 | 76.26 | ₹1913 Cr |
| 1,715 | ₹97757 Cr | 26.33 | 17.95 | 96.84 | ₹3505 Cr |
| 2,020.5 | ₹92007 Cr | 16.64 | 30.95 | 154.35 | ₹5333 Cr |
| 141 | ₹156 Cr | 40.44 | — | 3.83 | ₹4 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| — | — | — | — |
| ₹6 Cr | ₹78 L | ₹70 L | ₹70 L |
| ₹4 Cr | ₹6 Cr | ₹1 Cr | ₹23 L |
| ₹4 Cr | ₹6 Cr | ₹1 Cr | ₹23 L |
| ₹11 Cr | ₹6 Cr | ₹2 Cr | ₹93 L |
| ₹14 L | ₹91 L | ₹97 L | ₹69 L |
| ₹2 Cr | ₹72 L | ₹85 L | ₹25 L |
| -₹2 L | ₹2 L | ₹3 L | ₹2 L |
| ₹16 L | ₹16 L | ₹7 L | ₹5 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
| — | — | — | — |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr |
| ₹3 Cr | ₹83 L | ₹45 L | ₹51 L |
| ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr |
| ₹2 Cr | ₹86 L | ₹67 L | ₹20 L |
| ₹15 Cr | ₹12 Cr | ₹10 Cr | ₹8 Cr |
| ₹28 Cr | ₹20 Cr | ₹14 Cr | ₹9 Cr |
| ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹3 Cr |
| — | — | — | — |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹94 L |
| ₹14 L | ₹11 L | ₹6 L | ₹3 L |
| ₹96 L | ₹1 Cr | ₹1 Cr | ₹92 L |
| ₹13 L | ₹13 L | ₹1 Cr | ₹1 Cr |
| ₹0 | ₹71 L | ₹67 L | ₹0 |
| ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| — | — | — | — |
| ₹72 L | ₹1 Cr | ₹2 Cr | ₹50 L |
| ₹25 Cr | ₹16 Cr | ₹9 Cr | ₹6 Cr |
| ₹20 L | ₹64,000 | ₹12 L | ₹14 L |
| ₹1 L | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹74 L | ₹46 L | ₹34 L |
| ₹27 Cr | ₹18 Cr | ₹11 Cr | ₹7 Cr |
| ₹12 Cr | ₹6 Cr | ₹91 L | -₹18 L |
| ₹28 Cr | ₹20 Cr | ₹14 Cr | ₹9 Cr |
| ₹17 | ₹82 | ₹28 | ₹13 |
| ₹17 | ₹10 | ₹4 | ₹2 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| ₹6 Cr | ₹2 Cr | ₹1 Cr | ₹16 L |
| ₹93 L | ₹94 L | ₹75 L | ₹44 L |
| -₹7 Cr | -₹6 Cr | -₹2 Cr | -₹2 Cr |
| -₹17 L | -₹3 Cr | -₹30 L | -₹1 Cr |
| -₹16 L | -₹4 Cr | -₹32 L | -₹1 Cr |
| ₹87 L | -₹54,000 | -₹91 L | -₹20,000 |
| -₹51 L | ₹4 Cr | ₹1 Cr | ₹1 Cr |
| ₹19 L | -₹12 L | -₹1 L | ₹10 L |
| ₹63,000 | ₹12 L | ₹14 L | ₹3 L |
| ₹20 L | ₹64,000 | ₹12 L | ₹14 L |
Fundamental Ratios
Consolidated
Standalone
No results found
Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 6
Bearish signals: 0 out of 9 oscillators
RSI
69.69Buy
STOCH %K
76.99Neutral
MACD Level(12,26)
12.52Buy
Ultimate Oscillator
65.62Buy
Aroon Oscillator
94.00Buy
BOP
0.22Buy
CCI
73.99Neutral
Williams %R
-23.01Neutral
Momentum
43.46Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
139.78Buy
SMA 9
143.06Sell
EMA 21
127.16Buy
SMA 21
120.26Buy
EMA 50
112.17Buy
SMA 50
110.74Buy
EMA 200
95.59Buy
SMA 200
87.42Buy
WMA 20
132.58Buy
Pivot
Pivot
Classic
Resistance 5
164.50
Resistance 4
159.55
Resistance 3
154.60
Resistance 2
149.65
Resistance 1
146.35
Pivot
144.70
Support 1
141.40
Support 2
139.75
Support 3
134.80
Support 4
129.85
Support 5
124.90
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Mar 2026 | Sep 2025 | Jul 2025 |
|---|---|---|---|
| 39.48% | 50.66% | 50.66% | 50.66% |
| 0.00% | 1.91% | 6.04% | 9.71% |
| 0.00% | 0.00% | 0.00% | 1.43% |
| 0.00% | 0.00% | 0.00% | 0.00% |
| 60.52% | 47.43% | 43.30% | 38.20% |
Bulk & block deals
Name
Prashant P Sawant
Prashant P Sawant
Prakruti R Pali
Prakruti R Pali
Snehlata Manoj Kathotia
Prakruti R Pali
Prakruti R Pali
Prakruti R Pali
Vanita Anilkumar Kumbhare
Snehlata Manoj Kathotia
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | Purchase | 85.67 L | ₹140.44 | 61 K | Bulk | 0.716602 | BSE |
| 23 Oct 2026 | Purchase | 59.41 L | ₹129.16 | 46 K | Bulk | 0.540388 | BSE |
| 01 Sep 2026 | Purchase | 62.75 L | ₹123.04 | 51 K | Bulk | 0.599126 | BSE |
| 31 Aug 2026 | Purchase | 1.24 Cr | ₹123.88 | 1 L | Bulk | 1.174757 | BSE |
| 31 Aug 2026 | Purchase | 51.21 L | ₹119.10 | 43 K | Bulk | 0.505145 | BSE |
| 28 Aug 2026 | Purchase | 1.85 Cr | ₹112.81 | 1.64 L | Bulk | 1.926601 | BSE |
| 27 Aug 2026 | Purchase | 2.49 Cr | ₹103.69 | 2.40 L | Bulk | 2.819416 | BSE |
| 26 Aug 2026 | Purchase | 1.32 Cr | ₹95.59 | 1.38 L | Bulk | 1.621164 | BSE |
| 20 Aug 2026 | Sell | 56.73 L | ₹81.04 | 70 K | Bulk | 0.82233 | BSE |
| 20 Aug 2026 | Purchase | 54.73 L | ₹81.68 | 67 K | Bulk | 0.787087 | BSE |
Insider trading & SAST
Client name
Prakruti R Pali
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23 Sep 2026 | Other | Acquisition | 2.82 | 5.33 | 0 | — | 2.40 L | 27 Aug 2026 | Market | 4,54,000 | SAST | 29(1) | — |
Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The company operates under brand ‘Asston’. The company
Corporate Actions
Date
Type
Details
Company details
Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Asston Pharmaceuticals Share Price
141.00-2.05 (-1.43%)
+69.68% past 1 Year
News
Asston Pharmaceuticals informs about appointment of statutory auditors
Equity
APL
Asston Pharmaceuticals receives order for supplying various pharma products
Equity
APL
Asston Pharmaceuticals receives purchase order from Pharma company in west Africa
Equity
APL
Asston Pharmaceuticals bags purchase order worth Rs 6.52 crore
Equity
APL